SHMARQL

tocilizumab

<http://www.wikidata.org/entity/Q425154>

pharmaceutical drug
rdfs:label
"tocilizumab"@en
skos:altLabel
"MRA"@en
"R-1569"@en
"RG-1569"@en
"RHPM-1"@en
"atlizumab"@en
schema:description
"pharmaceutical drug"@en
schema:dateModified "2026-11-04T17:28:51+00:00"^^xsd:dateTime
schema:version 2564773730
wikibase:identifiers 20
wikibase:sitelinks 30
wikibase:statements 42
p:P10245 wd:statement/Q425154-ed7641f5-4c34-c149-90b7-436c5d51dfd9
p:P10283 wd:statement/Q425154-42E02D47-00D5-49F6-939C-6FEE1703A615
p:P11143 wd:statement/Q425154-939643BB-0084-47D3-A79B-6BDEFA69860D
p:P127 wd:statement/Q425154-3a3be771-4a0d-84a0-390f-0f4d161cd3e2
p:P1552 wd:statement/Q425154-B341BF4B-11D8-40BF-92FF-ADA03BA03D19
p:P176 wd:statement/Q425154-d9532056-4985-094a-32eb-1b9a8584681f
p:P2115 wd:statement/Q425154-6F696EEC-DFF4-44BA-8CAF-681F558C1166
p:P2175 wd:statement/Q425154-1336D31D-7C29-42CC-9774-61092292C53E
wd:statement/Q425154-294CEF13-605C-4C5C-AD0D-6252E3AAE1A6
wd:statement/Q425154-40037E82-D717-4758-9BB8-75C530B394E4
wd:statement/Q425154-535EA56A-C6C5-422D-951E-D316A0463F01
wd:statement/Q425154-89C9F919-9D59-4780-9461-C766E110126D
wd:statement/Q425154-E5A7CCF4-CBDA-41C3-AD25-C1101A5E9BEB
wd:statement/Q425154-EED73424-1125-4104-9C01-E9F3699BE4EB
wd:statement/Q425154-ff707d25-4b31-2b56-6354-8e44a7a1aa76
p:P2275 wd:statement/Q425154-C2E7F196-2389-42DE-B27C-067817E71291
p:P231 wd:statement/Q425154-ACD275A1-1B27-4A73-9CE9-B188794FAFEB
p:P267 wd:statement/Q425154-FC33F2AC-C58D-4C99-97B0-897A2287461D
p:P268 wd:statement/Q425154-cc92b9b5-41c4-f9c5-b180-cab87b9372f5
p:P269 wd:statement/Q425154-528c008c-4697-222b-00f3-9e2f300244d1
p:P279 wd:statement/Q425154-10E8B342-FEAE-4D27-AACE-420B3A5A515D
p:P2868 wd:statement/Q425154-665D0C1C-D379-470F-8722-C3646410CD4B
p:P31 wd:statement/Q425154-15B66C37-0C19-45A4-B8C1-591EDE22BA01
p:P3222 wd:statement/Q425154-06A71CBE-762D-47D9-BA54-6CCD9222E58E
p:P3345 wd:statement/Q425154-8216F353-B669-4F4E-9B44-7742188E6656
p:P3350 wd:statement/Q425154-2fac62f2-4c71-06a8-c766-81f33284e53a
p:P3489 wd:statement/Q425154-5E83E177-7884-4F8F-8191-5E495F87C2E0
p:P3493 wd:statement/Q425154-0426E238-F606-4E2A-8538-4AA176327C1F
p:P366 wd:statement/Q425154-E37DFF13-3641-40C9-B0E6-67B8EDB8704F
p:P3780 wd:statement/Q425154-BA219A7A-023D-40AE-B472-2E132582685B
p:P4250 wd:statement/Q425154-8E5AD9E5-B36C-4792-BA75-ECB9CE6D62A8
p:P4527 wd:statement/Q425154-89c64eda-4bec-dc35-6ad1-57953662a9e3
p:P5008 wd:statement/Q425154-ABEB7768-952D-4ADC-A140-4BB4EC98F8F8
p:P592 wd:statement/Q425154-F5E28BCF-54EB-4490-AA8D-F60CF0267E58
p:P595 wd:statement/Q425154-5ca1d14b-4763-d7da-a535-2818e971b456
p:P6366 wd:statement/Q425154-035F0CFF-7F38-4DD6-8245-25F90199353E
p:P646 wd:statement/Q425154-2FDC4F16-F5D6-4620-A13C-46CB1D51A2AF
p:P652 wd:statement/Q425154-0DFEE643-39FD-47BA-A306-4B430A6EF919
p:P665 wd:statement/Q425154-A9A0E9B2-CCF5-437D-AD7B-8CE924E1D41C
p:P715 wd:statement/Q425154-A8EFF9A2-687F-46FC-B7FF-91CB0DB3EC52
p:P7830 wd:statement/Q425154-9448DCF6-633A-4013-A2FB-A4EBE8E41726
p:P8026 wd:statement/Q425154-448831FC-83F3-4FB6-88D1-EA8C5301716B
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000180629>
p:direct-normalized/P268 <http://data.bnf.fr/ark:/12148/cb16764118r#about>
p:direct-normalized/P269 <http://www.idref.fr/178144762/id>
p:direct-normalized/P4527 <http://data.parliament.uk/terms/468363>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1237022>
p:direct-normalized/P6366 <https://makg.org/entity/2777178219>
p:direct-normalized/P665 <http://www.kegg.jp/entry/D02596>
wdt:P10245 "a611004"
wdt:P10283 "C2777178219"
wdt:P11143 "Tocilizumab"
wdt:P127 Hoffmann-La Roche
wdt:P1552 biopharmaceutical
wdt:P176 Hoffmann-La Roche
wdt:P2115 "N0000180629"
wdt:P2175 polyarthritis
arthritis
systemic-onset juvenile idiopathic arthritis
polymyalgia rheumatica
Castleman's disease
Takayasu's arteritis
giant cell arteritis
COVID-19
wdt:P2275 "tocilizumab"@en
wdt:P231 "375823-41-9"
wdt:P267 "L04AC07"
wdt:P268 "16764118r"
wdt:P269 "178144762"
wdt:P279 chemical compound
wdt:P2868 monoclonal antibody
wdt:P31 type of chemical entity
wdt:P3222 "tocilizumab"
wdt:P3345 "612865"
wdt:P3350 "8394"
wdt:P3489 US pregnancy category C
wdt:P3493 boxed warning
wdt:P366 medication
wdt:P3780 Roactemra
wdt:P4250 20.0^^xsd:decimal
wdt:P4527 "468363"
wdt:P5008 WikiProject COVID-19
wdt:P592 "CHEMBL1237022"
wdt:P595 "6881"
wdt:P6366 "2777178219"
wdt:P646 "/m/027yz2q"
wdt:P652 "I031V2H011"
wdt:P665 "D02596"
wdt:P715 "DB06273"
wdt:P7830 "Tocilizumab"
wdt:P8026 LiverTox toxicity likelihood category C
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata